Open Access
ARTICLE
COUNTERPOINT: Urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male
Richard W. Casey
The Male Health Centre, Oakville, Ontario, Canada
Address correspondence to Dr. Richard W. Casey, The Male Health Centre, 1235 Trafalgar Road, Suite 407, Oakville, Ontario, L6J 3Pl
Canadian Journal of Urology 2002, 9(6), 1681-1683.
Abstract
The recent interest in the potential applications of new testosterone preparations has stimulated industry and physicians to develop indications for their use. Despite little scientific evidence to support the widespread application of testosterone in aging men, a clinical symptom complex called Partial Androgen Deficiency in the Aging Male (PAD AM) has been described. Many of these symptoms can be successfully treated without testosterone administration. The author suggests that prospective randomized clinical trials are necessary to support the application of testosterone in the PADAM patient and until then physicians take a more balanced approach in this patient population.
Keywords
andropause, testosterone, libido, osteoporosis, replacement therapy, erectile dysfunction
Cite This Article
APA Style
Casey, R.W. (2002). COUNTERPOINT: Urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male. Canadian Journal of Urology, 9(6), 1681–1683.
Vancouver Style
Casey RW. COUNTERPOINT: Urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male. Can J Urology. 2002;9(6):1681–1683.
IEEE Style
R.W. Casey, “COUNTERPOINT: Urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male,” Can. J. Urology, vol. 9, no. 6, pp. 1681–1683, 2002.
Copyright © 2002 The Canadian Journal of Urology.